.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Express Scripts
McKinsey
Fish and Richardson
QuintilesIMS
Farmers Insurance
Queensland Health
Merck
Mallinckrodt
Teva

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204410

« Back to Dashboard
NDA 204410 describes OPSUMIT, which is a drug marketed by Actelion Pharms Ltd and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. Additional details are available on the OPSUMIT profile page.

The generic ingredient in OPSUMIT is macitentan. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the macitentan profile page.

Summary for 204410

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:4

Pharmacology for NDA: 204410

Suppliers and Packaging for NDA: 204410

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OPSUMIT
macitentan
TABLET;ORAL 204410 NDA Actelion Pharmaceuticals US, Inc. 66215-501 66215-501-15 1 BLISTER PACK in 1 CARTON (66215-501-15) > 15 TABLET, FILM COATED in 1 BLISTER PACK
OPSUMIT
macitentan
TABLET;ORAL 204410 NDA Actelion Pharmaceuticals US, Inc. 66215-501 66215-501-30 1 BOTTLE in 1 CARTON (66215-501-30) > 30 TABLET, FILM COATED in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Oct 18, 2013TE:RLD:Yes
Regulatory Exclusivity Expiration:Oct 18, 2018
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Regulatory Exclusivity Expiration:Oct 18, 2020
Regulatory Exclusivity Use:ORPHAN DRUG EXCLUSIVITY
Patent:► SubscribePatent Expiration:Oct 12, 2022Product Flag?YSubstance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Mallinckrodt
Deloitte
Colorcon
Chubb
US Department of Justice
QuintilesIMS
AstraZeneca
Argus Health
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot